Management of myopericarditis

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 2, 2013, Pages 193-201

  Imazio, Massimo ^a   Cooper, Leslie T ^b  

^a MARIA VITTORIA HOSPITAL   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

diagnosis; myopericarditis; pericarditis; perimyocarditis; prognosis; therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CLOZAPINE; COLCHICINE; CORTICOSTEROID; CREATINE KINASE MB; DIPHTHERIA PERTUSSIS TETANUS VACCINE; FLUOROURACIL; IBUPROFEN; INDOMETACIN; MESALAZINE; PHENYTOIN; SMALLPOX VACCINE; TROPONIN I;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FATIGUE; FEVER; GASTROENTERITIS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MYALGIA; MYOCARDITIS; MYOPERICARDITIS; PERICARDIAL EFFUSION; PERICARDITIS; PHYSICAL ACTIVITY; PNEUMONIA; PROGNOSIS; REMISSION; SEDENTARY LIFESTYLE; ST SEGMENT ELEVATION; SYMPTOM; T WAVE INVERSION; THORAX PAIN; THORAX RADIOGRAPHY; TONSILLITIS;

ANIMALS; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDITIS; PERICARDITIS; PROGNOSIS;

EID: 84873896623     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.12.184     Document Type: Article

References (80)

1. Imazio M, Demichelis B, Cecchi E et al. Cardiac troponin I in acute pericarditis. J. Am. Coll. Cardiol. 42(12), 2144-2148 (2003).
2. Spodick DH. Myopericarditis/perimyocarditis. In: The Pericardium. A Comprehensive Textbook. Marcel Dekker, Inc. NY, USA, 114-125 (1997).
3. Martin M, Le W, Marc D, Tischler. Pericardial diseases. In: Brauwald's Heart Diseases. A Textbook of Cardiovascular Medicine. (9th Edition). Saunders/Elsevier, PA, USA (2012).
4. Imazio M, Trinchero R. The spectrum of inflammatory myopericardial diseases. Int. J. Cardiol. 144(1), 134 (2010).
5. Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int. J. Cardiol. 127(1), 17-26 (2008).
6. Imazio M, Cecchi E, Demichelis B et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 94(4), 498-501 (2008).
7. Lee WS, Lee KJ, Kwon JE et al. Acute viral myopericarditis presenting as a transient effusive-constrictive pericarditis caused by coinfection with coxsackieviruses A4 and B3. Korean J. Intern. Med. 27(2), 216-220 (2012).
8. Fernández-Ruiz M, Muñoz-Codoceo C, López-Medrano F et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. Intern. Med. 47(22), 1963-1966 (2008).
9. Zubiaurre L, Zapata E, Bujanda L et al. Cytomegalovirus hepatitis and myopericarditis carditis. World J. Gastroenterol. 13(4), 647-648 (2007).
10. Roubille F, Gahide G, Moore-Morris T et al. Epstein-Barr virus (EBV) and acute myopericarditis in an immunocompetent patient: first demonstrated case and discussion. Intern. Med. 47(7), 627-629 (2008).
11. Park YM, Kang WC, Shin KC et al. Acute viral hepatitis A presented with myopericarditis. Int. J. Cardiol. 153(2), e34-e36 (2011).
12. De A, Myridakis D, Kerrigan M, Kiblawi F. Varicella myopericarditis mimicking myocardial infarction in a 17-year-old boy. Tex. Heart Inst. J. 38(3), 288-290 (2011).
13. Kao KL, Yeh SJ, Chen CC. Myopericarditis associated with Varicella Zoster virus infection. Pediatr. Cardiol. 31(5), 703-706 (2010).
14. Davoudi AR, Maleki AR, Beykmohammadi AR, Tayebi A. Fulminant myopericarditis in an immunocompetent adult due to pandemic 2009 (H1N1) influenza A virus infection. Scand. J. Infect. Dis. 44(6), 470-472 (2012).
15. Puzelli S, Buonaguro FM, Facchini M et al.; Surveillance Group for Pandemic H1N1 2009 Influenza Virus in Italy; Campania H1N1 Task Force. Cardiac tamponade and heart failure due to myopericarditis as a presentation of infection with the pandemic H1N1 2009 influenza A virus. J. Clin. Microbiol. 48(6), 2298-2300 (2010).
16. Klingel K, Hohenadl C, Canu A et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl Acad. Sci. USA 89(1), 314-318 (1992).
17. Wessely R, Henke A, Zell R, Kandolf R, Knowlton KU. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98(5), 450-457 (1998).
18. Wessely R, Klingel K, Santana LF et al. Transgenic expression of replicationrestricted enteroviral genomes in heart muscle induces defective excitationcontraction coupling and dilated cardiomyopathy. J. Clin. Invest. 102(7), 1444-1453 (1998).
19. Mayosi BM. Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart 93(10), 1176-1183 (2007).
20. Mayosi BM, Wiysonge CS, Ntsekhe M et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect. Dis. 6, 2 (2006).
21. Fica A, Seelmann D, Porte L, Eugenin D, Gallardo R. A case of myopericarditis associated to Campylobacter jejuni infection in the southern hemisphere. Braz. J. Infect. Dis. 16(3), 294-296 (2012).
22. Nevzorov R, Shleyfer E, Gourevitch A, Jotkowitz A, Porath A, Barski L. Campylobacter-associated myopericarditis with ventricular arrhythmia in a young hypothyroid patient. Isr. Med. Assoc. J. 12(8), 505-506 (2010).
23. Heinzl B, Köstenberger M, Nagel B, Sorantin E, Beitzke A, Gamillscheg A. Campylobacter jejuni infection associated with myopericarditis in adolescents: report of two cases. Eur. J. Pediatr. 169(1), 63-65 (2010).
24. Hull SR, Varma MP. Myopericarditis following Campylobacter infection. Ir. J. Med. Sci. 180(3), 753-755 (2011).
25. Alzand BS, Ilhan M, Heesen WF, Meeder JG. Campylobacter jejuni: enterocolitis and myopericarditis. Int. J. Cardiol. 144(1), e14-e16 (2010).
26. Kotilainen P, Lehtopolku M, Hakanen AJ. Myopericarditis in a patient with Campylobacter enteritis: a case report and literature review. Scand. J. Infect. Dis. 38(6-7), 549-552 (2006).
27. Vieira NB, Rodriguez-Vera J, Grade MJ, Santos C. Traveler's myopericarditis. Eur. J. Intern. Med. 19(2), 146-147 (2008).
28. Nkosi J, Thakrar A, Kumar K et al. Meningococcal serotype Y myopericarditis. Diagn. Microbiol. Infect. Dis. 63(2), 223-227 (2009).
29. Suesaowalak M, Cheung MM, Tucker D, Chang AC, Chu J, Arrieta A. Chlamydophila pneumoniae myopericarditis in a child. Pediatr. Cardiol. 30(3), 336-339 (2009).
30. Nisbet BC, Breyer M. Acute myopericarditis with focal ECG findings mimicking acute myocardial infarction. J. Emerg. Med. 39(5), e153-e158 (2010).
31. Talmon Y, Gilbey P, Fridman N, Wishniak A, Roguin N. Acute myopericarditis complicating acute tonsillitis: beware the young male patient with tonsillitis complaining of chest pain. Ann. Otol. Rhinol. Laryngol. 117(4), 295-297 (2008).
32. Habib G, Cohen L. Myopericarditis associated with streptococcal tonsilitis. Isr. Med. Assoc. J. 3(1), 74-75 (2001).
33. Lee YP, Hoi WH, Wong RC. A case of myopericarditis in a patient with methicillin-resistant Staphylococcus aureus community-acquired pneumonia. Ann. Acad. Med. Singap. 37(3), 243-242 (2008).
34. Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart 97(22), 1882-1892 (2011).
35. Nair JR, Somauroo JD, Over KE. Myopericarditis in giant cell arteritis: case report of diagnostic dilemma and review of literature. BMJ Case Rep. doi:10.1136/ bcr.12.2011.5469 (2012) (Epub ahead of print).
36. Daumas A, Rossi P, Jacquier A, Granel B. Myopericarditis revealing giant cell arteritis in the elderly. J. Rheumatol. 39(3), 665-666 (2012).
37. Park KT, Hong KS, Han SJ et al. Myopericarditis in a Korean young male with systemic lupus erythematosus. Korean Circ. J. 41(6), 334-337 (2011).
38. Vandergheynst F, Gosset J, van de Borne P, Decaux G. Myopericarditis revealing adult-onset Still's disease. Acta Clin. Belg. 60(4), 205-208 (2005).
39. Freeman HJ, Salh B. Recurrent myopericarditis with extensive ulcerative colitis. Can. J. Cardiol. 26(10), 549-550 (2010).
40. Sikkens EC, Schreuder TC, Fronczek J, Mulder CJ, Bouma G. Lymphocytic myopericarditis in a patient with previously undiagnosed Crohn's disease. Am. J. Gastroenterol. 105(1), 236-237 (2010).
41. Hyttinen L, Kaipiainen-Seppänen O, Halinen M. Recurrent myopericarditis in association with Crohn's disease. J. Intern. Med. 253(3), 386-388 (2003).
42. Anagnostopoulos G, Margantinis G, Tsiakos S, Kostopoulos P, Pantes A, Arvanitidis D. Myopericarditis associated with ulcerative colitis. N. Z. Med. J. 116(1185), U667 (2003).
43. García-Morán S, Sáez-Royuela F, Pérez-Alvarez JC, Gento E, Téllez J. Myopericarditis and mitral insufficiency associated with ulcerative colitis treated with mesalazine. Inflamm. Bowel Dis. 12(4), 334-335 (2006).
44. Çalik AN, Çeliker E, Velibey Y, Çagdas M, Güzelburç Ö. Initial dose effect of 5-fluorouracil: rapidly improving severe, acute toxic myopericarditis. Am. J. Emerg. Med. 30(1), 257.e1-3 (2012).
45. Atwater BD, Ai Z, Wolff MR. Fulminant myopericarditis from phenytoin-induced systemic lupus erythematosus. WMJ 107(6), 298-300 (2008).
46. Razminia M, Salem Y, Devaki S, Shah N, Khosla S. Clozapine induced myopericarditis: early recognition improves clinical outcome. Am. J. Ther. 13(3), 274-276 (2006).
47. Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H. Mesalazine-induced myopericarditis in a patient with ulcerative colitis. Int. J. Colorectal Dis. 21(2), 199-200 (2006).
48. Mora LF, Khan AH, Sperling LS. Cardiac complications after smallpox vaccination. South. Med. J. 102(6), 615-619 (2009).
49. Arness MK, Eckart RE, Love SS et al. Myopericarditis following smallpox vaccination. Am. J. Epidemiol. 160(7), 642-651 (2004).
50. Eckart RE, Love SS, Atwood JE et al.; Department of Defense Smallpox Vaccination Clinical Evaluation Team. Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J. Am. Coll. Cardiol. 44(1), 201-205 (2004).
51. Wollenberg A, Engler R. Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr. Opin. Allergy Clin. Immunol. 4(4), 271-275 (2004).
52. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J. Am. Coll. Cardiol. 43(9), 1503-1510 (2004).
53. Halsell JS, Riddle JR, Atwood JE et al.; Department of Defense Smallpox Vaccination Clinical Evaluation Team. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 289(24), 3283-3289 (2003).
54. Thanjan MT, Ramaswamy P, Lai WW, Lytrivi ID. Acute myopericarditis after multiple vaccinations in an adolescent: case report and review of the literature. Pediatrics 119(6), e1400-e1403 (2007).
55. Sharma U, Tak T. A report of 2 cases of myopericarditis after vaccinia virus (smallpox) immunization. WMJ 110(6), 291-294 (2011).
56. Salemi S, D'Amelio R. Could autoimmunity be induced by vaccination? Int. Rev. Immunol. 29(3), 247-269 (2010).
57. Boccara F, Benhaiem-Sigaux N, Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 120(2), 671-672 (2001).
58. Talmon Y, Ishai R, Samet A, Sturman A, Roguin N. Acute myopericarditis complicating acute tonsillitis: a prospective study. Ann. Otol. Rhinol. Laryngol. 118(8), 556-558 (2009).
59. Porela P, Kytö V, Nikus K, Eskola M, Airaksinen KE. PR depression is useful in the differential diagnosis of myopericarditis and ST elevation myocardial infarction. Ann. Noninvasive Electrocardiol. 17(2), 141-145 (2012).
60. Chan TC, Brady WJ, Pollack M. Electrocardiographic manifestations: acute myopericarditis. J. Emerg. Med. 17(5), 865-872 (1999).
61. Abu Fanne R, Banai S, Chorin U, Rogowski O, Keren G, Roth A. Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology 119(3), 134-139 (2011).
62. Ong P, Athansiadis A, Hill S et al. Usefulness of pericardial effusion as new diagnostic criterion for noninvasive detection of myocarditis. Am. J. Cardiol. 108(3), 445-452 (2011).
63. Friedrich MG, Sechtem U, Schulz-Menger J et al.; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J. Am. Coll. Cardiol. 53(17), 1475-1487 (2009).
64. Childs H, Friedrich MG. Cardiovascular magnetic resonance imaging in myocarditis. Prog. Cardiovasc. Dis. 54(3), 266-275 (2011).
65. Kim EY, Chang SA, Lee YK, Choi JO, Choe YH. Early non-invasive diagnosis and treatment of acute eosinophilic myopericarditis by cardiac magnetic resonance. J. Korean Med. Sci. 26(11), 1522-1526 (2011).
66. Stensaeth KH, Fossum E, Hoffmann P, Mangschau A, Klow NE. Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int. J. Cardiovasc. Imaging 27(3), 355-365 (2011).
67. Ferreira ND, Bettencourt N, Rocha J et al. Diagnosis of acute myopericarditis by delayed-enhancement multidetector computed tomography. J. Am. Coll. Cardiol. 60(9), 868 (2012).
68. Takakuwa KM, Ku BS, Halpern EJ. Myopericarditis diagnosed by a 64-slice coronary CT angiography 'triple rule out' protocol. Int. J. Emerg. Med. 3(4), 447-449 (2010).
69. Cooper LT, Baughman KL, Feldman AM et al.; American Heart Association; American College of Cardiology; European Society of Cardiology. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116(19), 2216-2233 (2007).
70. Lurz P, Eitel I, Adam J et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc. Imaging 5(5), 513-524 (2012).
71. Machado S, Roubille F, Gahide G et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann. Cardiol. Angeiol. (Paris) 59(1), 1-7 (2010).
72. Kobayashi D, Aggarwal S, Kheiwa A, Shah N. Myopericarditis in children: elevated troponin I level does not predict outcome. Pediatr. Cardiol. 33(7), 1040-1045 (2012).
73. Buiatti A, Merlo M, Pinamonti B, De Biasio M, Bussani R, Sinagra G. Clinical presentation and long-term follow-up of perimyocarditis. J. Cardiovasc. Med. (Hagerstown) doi:10.1714/1188.13164 (2012) (Epub ahead of print).
74. Costanzo-Nordin MR, Reap EA, O'Connell JB, Robinson JA, Scanlon PJ. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J. Am. Coll. Cardiol. 6(5), 1078-1082 (1985).
75. Rezkalla S, Khatib G, Khatib R. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. J. Lab. Clin. Med. 107(4), 393-395 (1986).
76. Khatib R, Reyes MP, Smith F, Khatib G, Rezkalla S. Enhancement of coxsackievirus B4 virulence by indomethacin. J. Lab. Clin. Med. 116(1), 116-120 (1990).
77. Imazio M, Brucato A, Forno D et al. Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis. Heart 98(14), 1078-1082 (2012).
78. Durakovic Z, Misigoj Durakovic M, Skavic J, Tomljenovic A. Myopericarditis and sudden cardiac death due to physical exercise in male athletes. Coll. Antropol. 32(2), 399-401 (2008).
79. Seidenberg PH, Haynes J. Pericarditis: diagnosis, management, and return to play. Curr. Sports Med. Rep. 5(2), 74-79 (2006).
80. Pelliccia A, Corrado D, Bjørnstad HH et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur. J. Cardiovasc. Prev. Rehabil. 13(6), 876-885 (2006).